Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Parkinson's Disease
Interventions
DRUG

Rasagiline

DRUG

Placebo

Trial Locations (40)

Unknown

Teva Investigational Site 036, Birmingham

Teva Investigational Site 047, Sun City

Teva Investigational Site 004, Irvine

Teva Investigational Site 016, La Jolla

Teva Investigational Site 042, Long Beach

Teva Investigational Site 041, San Bernardino

Teva Investigational Site 048, Denver

Teva Investigational Site 038, Englewood

Teva Investigational Site 035, Danbury

Teva Investigational Site 034, Manchester

Teva Investigational Site 037, New London

Teva Investigational Site 026, Washington D.C.

Teva Investigational Site 015, Boca Raton

Teva Investigational Site 021, Jacksonville

Teva Investigational Site 033, Ormond Beach

Teva Investigational Site 020, Port Charlotte

Teva Investigational Site 017, St. Petersburg

Teva Investigational Site 019, Atlanta

Teva Investigational Site 003, Chicago

Teva Investigational Site 006, Chicago

Teva Investigational Site 008, Chicago

Teva Investigational Site 025, Kansas City

Teva Investigational Site 009, Lexington

Teva Investigational Site 046, Baton Rouge

Teva Investigational Site 024, Boston

Teva Investigational Site 031, Las Vegas

Teva Investigational Site 030, New Brunswick

Teva Investigational Site 014, Albany

Teva Investigational Site 045, Commack

Teva Investigational Site 013, Kingston

Teva Investigational Site 010, New York

Teva Investigational Site 040, New York

Teva Investigational Site 022, Asheville

Teva Investigational Site 005, Raleigh

Teva Investigational Site 018, Toledo

Teva Investigational Site 028, Philadelphia

Teva Investigational Site 012, Nashville

Teva Investigational Site 002, San Antonio

Teva Investigational Site 011, Salt Lake City

Teva Investigational Site 001, La Crosse

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT01723228 - Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter